Akums Drugs & Pharmaceuticals Share Price Jumps to Fresh 52-Week High at Rs 838: Here’s Why
- September 23, 2026
- Posted by: Harsh Piplani
- Category: News
Akums Drugs & Pharmaceuticals Share Price moved to Rs 830.85 after a 2.66% rise, marking a fresh 52-week high at Rs 837.90 with a market capitalisation of Rs 12,925.98 crore. The stock’s latest move also kept Akums Drugs & Pharmaceuticals Share Price in focus in today’s share market discussion because the day’s high matched its yearly high, while the current price remained close to that level at the close of the reported data point. On the supplied data, the event is clear and measurable; however, it does not establish a company-specific catalyst. For readers tracking Akums Drugs & Pharmaceuticals Share Price Today, the key facts are the price, the day’s range, turnover of Rs 0.34 crore and the fresh 52-week high. That combination makes Akums Drugs & Pharmaceuticals Stock News relevant for investors watching the latest price action and the valuation backdrop on Univest.
Akums Drugs & Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 830.85 |
| Previous Close | Rs 809.3 |
| Today's Move | +Rs 21.55 (+2.66%) |
| Open | Rs 817.9 |
| High | Rs 837.9 |
| Low | Rs 816.45 |
| Turnover | Rs 0.34 crore |
| Market Capitalisation | Rs 12,925.98 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 830.85 versus the previous close of Rs 809.3, a rise of 2.66%. The stock opened at Rs 817.9, reached a high of Rs 837.9 and touched a low of Rs 816.45.
Akums Drugs & Pharmaceuticals Share Price opened at Rs 817.90, traded between Rs 816.45 and Rs 837.90, and closed at Rs 830.85 versus the previous close of Rs 809.30. The absolute gain was Rs 21.55, or 2.66%, and the day’s high was exactly the 52-week high at Rs 837.90. That means the stock finished near the upper end of its reported range, with a turnover of Rs 0.34 crore supporting the day’s measured move. In simple terms, the price data confirms a fresh 52-week high and a close above the previous close, which is why Akums Drugs & Pharmaceuticals Share Price Today, Akums Drugs & Pharmaceuticals Share Price Live and Akums Drugs & Pharmaceuticals Share Price Update are drawing search interest. This is the core event behind today’s Akums Drugs & Pharmaceuticals Stock News and Akums Drugs & Pharmaceuticals Share News, and it sets up the fundamental comparison that follows.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 12,925.98 crore |
| P/E Ratio | 43.66x |
| P/B Ratio | 3.73x |
| ROE | 8.06% |
| ROCE | 14.77% |
| EPS | Rs 18.53 |
| Book Value Per Share | Rs 216.98 |
| Dividend Yield | 0.37% |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) fundamental metrics show P/E 43.66x, P/B 3.73x, ROE 8.06%, ROCE 14.77%. These figures provide context only and are not a buy or sell signal.
Akums Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 12925.98 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.66x, P/B at 3.73x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.37%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.63x, median ROE of 11.7%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 43.66x |
| Benchmark Median P/E | 31.63x |
| Benchmark Average P/E | 49.58x |
| Benchmark P/E Range | 3.48x to 765.12x |
| Company P/B Ratio | 3.73x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 8.06% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 14.77% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 12,925.98 crore |
| Benchmark Median Market Cap | Rs 718.76 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 43.66x, which is above the benchmark median of 31.63x, a difference of +38.03%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.7%, a difference of -31.11%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.32%, a difference of +10.89%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sudeep Pharma Ltd. | SUDEEPPHRM | 12,924.71 | 74.14 | 14.66 | 25.37 | 28.5 |
| CORONA Remedies Ltd. | CORONA | 13,542.68 | 67.1 | 16.55 | 27.36 | 31.74 |
| Natco Pharma Ltd. | NATCOPHARM | 14,624.32 | 12.76 | 1.56 | 16.3 | 17.16 |
| Strides Pharma Science Ltd. | STAR | 11,400.84 | 18.26 | 3.42 | 20.31 | 18.57 |
| Sequent Scientific Ltd. | VIYASH | 11,120.18 | 64.91 | 3.95 | 9.06 | 13.1 |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 43.66x compared with the displayed peer median of 64.91x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 20.31% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 18.57%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 12,925.98 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Akums Drugs & Pharmaceuticals
- Akums Drugs & Pharmaceuticals Share Price hit a fresh 52-week high of Rs 837.90.
- The stock closed at Rs 830.85 after a gain of Rs 21.55, or 2.66%.
- Market capitalisation stood at Rs 12,925.98 crore.
- P/E was 43.66, P/B was 3.73, ROE was 8.06% and ROCE was 14.77%.
- Revenue for Jun 2026 was Rs 11,666.29 crore and net profit was Rs 1,000.10 crore.
About Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile places Akums Drugs & Pharmaceuticals Share Price within that classification, and the reported financial data shows revenue, profit, earnings per share, book value and dividend yield that can be tracked alongside Akums Drugs & Pharmaceuticals Company News and Akums Drugs & Pharmaceuticals Latest News. For readers following Akums Drugs & Pharmaceuticals NSE and Akums Drugs & Pharmaceuticals BSE searches, the company’s market cap, valuation and quarterly financials are the main verified data points in the present set.
Track Akums Drugs & Pharmaceuticals Share Price on Univest
Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Akums Drugs & Pharmaceuticals Share Price on Univest for live share price, market capitalisation, shareholding pattern, fundamental ratios, 52-week levels, company financials and market insights. Univest also helps readers review Akums Drugs & Pharmaceuticals Stock Performance, Akums Drugs & Pharmaceuticals Share Price Today and Akums Drugs & Pharmaceuticals Stock Analysis in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Akums Drugs & Pharmaceuticals Share Price hit a fresh 52-week high?
Ans. The supplied data confirms a fresh 52-week high at Rs 837.90, but it does not establish a company-specific catalyst. The stock closed at Rs 830.85, up Rs 21.55, or 2.66%, for the session.
What was the latest closing price of Akums Drugs & Pharmaceuticals Share Price?
Ans. Akums Drugs & Pharmaceuticals Share Price closed at Rs 830.85 in the reported session. That was above the previous close of Rs 809.30 and within a day’s range that topped at the fresh yearly high of Rs 837.90.
What is the 52-week high for Akums Drugs & Pharmaceuticals Share Price?
Ans. The 52-week high for Akums Drugs & Pharmaceuticals Share Price is Rs 837.90. The day’s high matched that level, making it a fresh 52-week high event in the supplied data.
What is the market capitalisation of Akums Drugs & Pharmaceuticals?
Ans. Akums Drugs & Pharmaceuticals has a market capitalisation of Rs 12,925.98 crore. That places it well above the industry median in the supplied healthcare benchmark and provides useful context for Akums Drugs & Pharmaceuticals Share Price.
How does Akums Drugs & Pharmaceuticals Share Price compare on valuation?
Ans. Akums Drugs & Pharmaceuticals Share Price carries a P/E of 43.66 and a P/B of 3.73. Those levels sit above the same-industry median values but below the same-industry averages in the supplied benchmark set.
What do EPS and book value show for Akums Drugs & Pharmaceuticals?
Ans. EPS is Rs 18.53 and book value is Rs 216.98 per share. EPS shows earnings attributable to each share, while book value shows accounting net worth per share for Akums Drugs & Pharmaceuticals.
How do revenue and net profit look in the latest figures?
Ans. The latest supplied figures show revenue of Rs 11,666.29 crore and net profit of Rs 1,000.10 crore for Jun 2026. These numbers add financial context to Akums Drugs & Pharmaceuticals Share Price and Stock News.
How does Akums Drugs & Pharmaceuticals compare with peers?
Ans. Akums Drugs & Pharmaceuticals sits near several peers by market cap and trades at a higher P/E than Natco Pharma and Strides Pharma Science. Its ROCE is also above several listed comparables in the supplied peer set.
